Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients.

Zhang Q, Guo X, Zhao S, Pang X, Wang Y, Zhang Y, Chi B.

Exp Ther Med. 2016 Apr;11(4):1348-1354. Epub 2016 Jan 29.

2.

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience.

Sheen V, Nguyen H, Jimenez M, Agopian V, Vangala S, Elashoff D, Saab S.

J Clin Transl Hepatol. 2016 Mar 28;4(1):20-5. doi: 10.14218/JCTH.2015.00034. Epub 2016 Mar 15.

3.

Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.

Potretzke TA, Ziemlewicz TJ, Hinshaw JL, Lubner MG, Wells SA, Brace CL, Agarwal P, Lee FT Jr.

J Vasc Interv Radiol. 2016 May;27(5):631-8. doi: 10.1016/j.jvir.2016.01.136. Epub 2016 Mar 24.

PMID:
27017124
4.

Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area.

Kwak HW, Park JW, Koh YH, Lee JH, Yu A, Nam BH.

Liver Cancer. 2016 Feb;5(1):21-36. doi: 10.1159/000367756. Epub 2015 Dec 15.

5.

A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.

Nalpas B, Ichaï P, Jamot L, Carbonell N, Rudler M, Mathurin P, Durand F, Gerken G, Manns M, Trautwein C, Larrey D, Radenne S, Duvoux C, Leroy V, Bernuau J, Faivre J, Moniaux N, Bréchot C, Amouyal G, Amouyal P, Samuel D.

PLoS One. 2016 Mar 16;11(3):e0150733. doi: 10.1371/journal.pone.0150733. eCollection 2016.

6.

Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion.

Valerio C, Theocharidou E, Davenport A, Agarwal B.

World J Hepatol. 2016 Mar 8;8(7):345-54. doi: 10.4254/wjh.v8.i7.345. Review.

7.

Liver surgery in cirrhosis and portal hypertension.

Hackl C, Schlitt HJ, Renner P, Lang SA.

World J Gastroenterol. 2016 Mar 7;22(9):2725-35. doi: 10.3748/wjg.v22.i9.2725. Review.

8.

Advances in liver transplantation allocation systems.

Schilsky ML, Moini M.

World J Gastroenterol. 2016 Mar 14;22(10):2922-30. doi: 10.3748/wjg.v22.i10.2922. Review.

9.

Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.

Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J.

World J Gastroenterol. 2016 Feb 14;22(6):2133-41. doi: 10.3748/wjg.v22.i6.2133.

10.

Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure.

Zhou Q, Ding W, Jiang L, Xin J, Wu T, Shi D, Jiang J, Cao H, Li L, Li J.

Sci Rep. 2016 Feb 10;6:20759. doi: 10.1038/srep20759.

11.

Bibliometric analysis of the top-cited gastroenterology and hepatology articles.

Azer SA, Azer S.

BMJ Open. 2016 Feb 8;6(2):e009889. doi: 10.1136/bmjopen-2015-009889.

12.

The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.

Liu L, Zhao Y, Jia J, Chen H, Bai W, Yang M, Yin Z, He C, Zhang L, Guo W, Niu J, Yuan J, Cai H, Xia J, Fan D, Han G.

Sci Rep. 2016 Feb 2;6:19851. doi: 10.1038/srep19851.

13.

Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment.

Hartmann M, Szalai C, Saner FH.

World J Gastroenterol. 2016 Jan 28;22(4):1541-50. doi: 10.3748/wjg.v22.i4.1541. Review.

14.

Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.

Thomsen KL, Macnaughtan J, Tritto G, Mookerjee RP, Jalan R.

PLoS One. 2016 Jan 8;11(1):e0146076. doi: 10.1371/journal.pone.0146076. eCollection 2016.

15.

Orthotopic liver transplantation for giant liver haemangioma: A case report.

Lange UG, Bucher JN, Schoenberg MB, Benzing C, Schmelzle M, Gradistanac T, Strocka S, Hau HM, Bartels M.

World J Transplant. 2015 Dec 24;5(4):354-9. doi: 10.5500/wjt.v5.i4.354.

16.

Budd-Chiari syndrome.

Martens P, Nevens F.

United European Gastroenterol J. 2015 Dec;3(6):489-500. doi: 10.1177/2050640615582293. Review.

17.

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.

Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ.

Eur J Gastroenterol Hepatol. 2016 Apr;28(4):444-8. doi: 10.1097/MEG.0000000000000538.

18.

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

Merchante N, Téllez F, Rivero-Juárez A, Ríos-Villegas MJ, Merino D, Márquez-Solero M, Omar M, Recio E, Pérez-Pérez M, Camacho Á, Macías-Dorado S, Macías J, Lorenzo-Moncada S, Rivero A, Pineda JA; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

BMC Infect Dis. 2015 Dec 7;15:557. doi: 10.1186/s12879-015-1291-3.

19.

Prognostic impact of ICG-PDR in patients with hypoxic hepatitis.

Horvatits T, Kneidinger N, Drolz A, Roedl K, Rutter K, Kluge S, Trauner M, Fuhrmann V.

Ann Intensive Care. 2015 Dec;5(1):47. doi: 10.1186/s13613-015-0092-6. Epub 2015 Dec 4.

20.

Extended leukocyte differential count and C-reactive protein in septic patients with liver impairment: diagnostic approach to evaluate sepsis in intensive care unit.

Buoro S, Mecca T, Azzarà G, Apassiti Esposito S, Seghezzi M, Vavassori M, Crippa A, Marchesi G, Castellucci E, Ottomano C, Lippi G.

Ann Transl Med. 2015 Oct;3(17):244. doi: 10.3978/j.issn.2305-5839.2015.09.41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk